Response to Coppinger et al., Comment on "5α-reductase inhibitor exposure for dermatologic conditions does not increase the risk of female breast or gynecologic cancers: A population-based propensity score-matched cohort study"

Chen LC, Hsieh TYJ, Martin A, Senna MM. Response to Coppinger et al., Comment on "5α-reductase inhibitor exposure for dermatologic conditions does not increase the risk of female breast or gynecologic cancers: A population-based propensity score-matched cohort study". J Am Acad Dermatol. 2025;92(6):e211-e212.